Document
EPCLUSA, 214187, Letter (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Letter (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Label (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Label (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review Clinical MicrobiologyVirology Reviews (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Clinical MicrobiologyVirology Reviews (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review Summary Review (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Summary Review (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review Clinical Pharmacology and Biopharmaceutics Reviews (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Clinical Pharmacology and Biopharmaceutics Reviews (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review Approval Letters (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Approval Letters (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review Other Reviews (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Other Reviews (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review Proprietary Name Reviews (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Proprietary Name Reviews (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review Product Quality Reviews (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Product Quality Reviews (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review Printed Labeling (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Printed Labeling (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review OfficerEmployee List (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review OfficerEmployee List (Orange Book Jun. 10, 2021)
+ More Snippets
Document
IPR2018-00125, No. 3001-28 Exhibit - Ex 3001 (P.T.A.B. Apr. 3, 2018)
Cite Document
IPR2018-00125, No. 3001-28 Exhibit - Ex 3001 (P.T.A.B. Apr. 3, 2018)
+ More Snippets
Document
IPR2018-00125, No. 3001 Exhibit - Ex 3001 (P.T.A.B. Apr. 3, 2018)
Cite Document
IPR2018-00125, No. 3001 Exhibit - Ex 3001 (P.T.A.B. Apr. 3, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2008-21 Exhibit - Jonathan D Rockoff, FDA Approves Gileads Hepatitis C Drug THE WALL STREET JOURNAL, 2013 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2008-21 Exhibit - Jonathan D Rockoff, FDA Approves Gileads Hepatitis C Drug THE WALL STREET JOURNAL, 2013 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2001-14 Exhibit - Americas Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices, I MAK 2017 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2001-14 Exhibit - Americas Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices, I MAK 2017 (P.T.A.B. Mar. 19, 2018)
+ More Snippets